Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy
Conditions: Ovarian Cancer Interventions: Drug: Pembrolizumab; Drug: Bevacizumab; Drug: Cyclophosphamide Sponsors: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
Oral Prednisone in Treating LCH of Bone in Childhood and Adolescence
Conditions: Langerhans Cell Histiocytosis of Bone Interventions: Drug: Prednisone Sponsors: Shanghai Changzheng Hospital; First Affiliated Hospital of Zhejiang University; Peking University Third Hospital; National Sun Yat-sen University; Beijing Children ' s Hospital; Henan Cancer Hospital; Tianjin Hospital; First Affiliated Hospital, Sun Yat-Sen University; Second Hospital of Jilin University; Peking University People ' s Hospital; Jinling hospital Nanjing, Jiangsu, China; The First Affiliated Hospital of Nanchang University; The Third Affiliated Hospital of Southern Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
Randomized phase III trial evaluating motivational interviewing and text interventions to optimize adherence to breast cancer endocrine therapy (Alliance A191901): the GETSET protocol
DiscussionThis multisite study will not only define strategies to improve adherence to breast cancer oral therapies, but it will also potentially support strategies in large cooperative research groups that can increase delivery and tolerability of ET, involve diverse patient populations in clinical research, and engage patients effectively in interventional studies, using remote and cost-effective delivery methods.Trial registrationClinicaltrials.govNCT04379570. Registered on 7 May 2020. (Source: Trials)
Source: Trials - October 12, 2023 Category: Research Source Type: clinical trials
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
Conditions: Breast Cancer; Breast Neoplasm; Breast Cancer Stage IV Interventions: Drug: MBQ-167 Sponsors: MBQ Pharma; United States Department of Defense Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic HSCT
Conditions: Hematopoietic Stem Cell Transplantation; Low-Level Light Therapy; Stomatitis Interventions: Procedure: Double low-power laser therapy simultaneous applicated Sponsors: Instituto Nacional de Cancer, Brazil Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2023 Category: Research Source Type: clinical trials
Evaluation of Safety, Tolerability, Pharmacokinetics, Food Effect and Interaction With Midazolam in Healthy Volunteers After Oral Single and Multiple Ascending Dosing of KAND145
Conditions: Ovarian Cancer Interventions: Drug: KAND145; Drug: Placebo Sponsors: Kancera AB; LINK Medical Research AB; Q&Q Labs AB; CRST Oy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2023 Category: Research Source Type: clinical trials
Diagnostic Accuracy of Mobile Phone Imaging for Oral Cancer
Conditions: Teledentistry Oral Cancer Screening Interventions: Diagnostic Test: Diagnosis by mobile phone imaging Sponsors: Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials
Diagnostic Accuracy of Mobile Phone Imaging Compared to Conventional Clinical Examination for Oral Cancer Screening
Conditions: Premalignant Lesion; Oral Cancer Interventions: Diagnostic Test: Diagnosis by mobile phone imaging Sponsors: Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials
Oral Cancer Screening in Workplace: a Cross-sectional Study
Condition: Oral Cancer Intervention: Other: conventional oral examination Sponsor: Cairo University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
Conditions: Neuroblastoma; High-risk Neuroblastoma; Metastatic Neuroblastoma Interventions: Biological: OPT-821 (QS-21); Dietary Supplement: oral β-glucan Sponsors: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
Oral Cancer Screening in Workplace: a Cross-sectional Study
Conditions: Oral Cancer Interventions: Other: conventional oral examination Sponsors: Cairo University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
Conditions: HIV Infections; Oral Squamous Cell Carcinoma; Oropharyngeal Squamous Cell Carcinoma Interventions: Other: Group Meeting (Focus Group); Other: Questionnaires Sponsors: University of California, San Francisco; National Institute of Dental and Craniofacial Research (NIDCR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
Conditions: HIV Infections; Oral Squamous Cell Carcinoma; Oropharyngeal Squamous Cell Carcinoma Interventions: Other: Group Meeting (Focus Group); Other: Questionnaires Sponsors: University of California, San Francisco; National Institute of Dental and Craniofacial Research (NIDCR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients
Conditions: Malnutrition; Cancer; Inflammatory Bowel Diseases; Chronic Obstructive Pulmonary Disease (COPD); Hiv Intervention: Dietary Supplement: Fortimel Sponsor: Danone Specialized Nutrition Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
